JGC
ARCT icon

J. Goldman & Co’s Arcturus Therapeutics ARCT Stock Holding History

J. Goldman & Co’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,118
Closed -$408K – 573
2025
Q3 		$408K Buy
+22,118
New +$355K 0.02% 394
2025
Q2 		– Sell
-135,427
Closed -$1.43M – 462
2025
Q1 		$1.43M Sell
135,427
-160,618
-54% -$2.55M 0.05% 330
2024
Q4 		$5.02M Buy
+296,045
New +$5.57M 0.18% 196
2017
Q1 		– Sell
-37,143
Closed -$546K – 328
2016
Q4 		$546K Buy
+37,143
New +$555K 0.07% 253
2014
Q4 		– Hold
0
– – – 190
2014
Q3 		– Sell
-18,750
Closed -$2.44M – 276
2014
Q2 		$2.27M Buy
+18,750
New +$2.26M 0.35% 139

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return